In the mouse oxygen-induced retinopathy model, preconditioning ECFCs with EPO or ARA290 before delivery did not enhance vasoreparative function.
In plain wordsIn mice with retinal ischemia, pretreating repair cells with ARA290 or EPO before delivery did not improve their vessel repair.
- Peptide
- Cibinetide (ARA-290)
- Outcome
- No significant changeVasoreparative function of ECFCs preconditioned with ARA290 or EPO
- Study
mousen: not reported in source
Oxygen-induced retinopathy (OIR) mouse model of retinal ischemia- Outcome group
- Wound healing · Eye
- Studied dose
- Dose not stated
Source sentences
Preconditioning of ECFCs with EPO or ARA290 prior to delivery to the ischemic retina did not enhance vasoreparative function.
1 context sentence(design, population, supporting numbers)
Efficacy of ECFC transplantation therapy to promote retinal vascular repair in the presence and absence of ARA290 was studied in the oxygen induced retinopathy (OIR) model of retinal ischemia.